Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Follicular lymphoma

Tag: follicular lymphoma

Interim Results of Phase I Clinical Trial of TRPH-222 in R/R...

ADC Review | Editorial Team
The investigational drug TRPH-222 (previously known as CAT-02-106), a next-generation antibody-drug conjugate (ADC), is demonstrating early signs of efficacy in the interim results of...

Polatuzumab Vedotin Demonstrates Clinical Efficacy Across a Range of Diffuse Large...

Peter Hofland
Polatuzumab vedotin (DCDS4501A), a novel, targeted anti-cancer agent being developed by Genentech/Roche, is a first-in-class anti-CD79b antibody-drug conjugate or ADC currently being investigated for...

Phase II Trial of Denintuzumab Mafodotin Combination Therapy in Relapsed or...

ADC Review | Editorial Team
A randomized phase II clinical trial of denintuzumab mafodotin, also known as SGN-CD19A (SGN-19A), in combination with the second-line salvage regimen of rituximab (Rituxan®;...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X